AVELO
LIVE

Serial Number

79387466

Owner

Avelo AG

Attorney

Dianne M. Smith-Misemer

Filing Date

Dec 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AVELO Trademark

Serial Number: 79387466

AVELO is a trademark filed by Avelo AG on December 15, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Avelo AG (2 trademarks)

RĂ¼tistrasse 16

Entity Type: 25

Trademark Details

Filing Date

December 15, 2023

Registration Date

Not Registered

Goods & Services

Surgical apparatus and instruments; medical apparatus and instruments, for assessing and diagnosing infectious diseases; testing apparatus for medical use, namely, genetic testing apparatus for medical purposes; medical devices, namely, disposable medical devices for diagnosing and treating infectious diseases; medical diagnostic instruments in the nature of biomarker analyzers for infectious diseases diagnosis; clinical diagnosis apparatus in the nature of medical diagnostic apparatus for testing for viruses and infectious diseases; medical devices, namely, reaction vessels, fluid blocks for preparing and processing biological samples, cartridges for preparing and processing biological samples and optical detectors in the field of infections diseases

Chemical products for use in science, namely, chemical products used for infectious disease diagnostics; reagents and kits primarily comprising reagents for scientific use and for research in the field of the concentration, amplification, analysis, labeling and detection of biomarkers; reagents for scientific, diagnostic and clinical research; diagnostic reagents and tests in the nature of diagnostic preparations for infectious disease for use in clinical laboratories and research

Scientific and technological services as well as research and design services relating thereto; clinical and medical laboratory services for scientific purposes; medical, scientific and technical research services; biochemical research and development; industrial analysis services; medical and scientific research services in the field of health monitoring; pharmaceutical research and development services; quality control and authentication services; design and development of computers and software

Scientific apparatus and instruments, namely, scientific apparatus for analyzing and assessing the condition, stage or progress of infectious diseases; research apparatus and instruments, namely, medical imaging apparatus for analyzing and assessing the condition, stage or progress of infectious diseases; laboratory material and instruments for scientific and medical research and for research on biomarkers, included in this class, namely, laboratory swabs; downloadable computer software in the nature of software for medical monitoring of infectious diseases and analysis of biological and medical data; downloadable electronic publications, namely, books, magazines, manuals, and newsletters in the field of infectious diseases

Medical services; provision of advice relating to medical apparatus and instruments; consultant services relating to pharmaceutical and medical products; medical analysis services for diagnosing diseases; medical diagnostic testing, monitoring and reporting services; medical evaluation services; providing information in the field of disease prevention, screening, diagnosis and treatment; provision of information in the field of medicine

Pharmaceutical products, namely, pharmaceutical products for treating respiratory diseases; medical, namely, bacterial preparations for medical purposes; hygienic products for medicine, namely, disinfectants for hygienic purposes; diagnostic preparations for clinical, medical and laboratory use, namely, diagnostic preparations for infectious diseases for medical use; diagnostic testing materials for medical use sold in kit form, namely, diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; diagnostic preparations for medical use; test kits comprising medical diagnostic reagents and tests in the nature of medical diagnostic test strips for infectious disease analysis; reagents and kits primarily comprising reagents for medical, clinical, medical laboratory or diagnostic use in connection with the concentration, amplification, analysis, labeling and detection of biomarkers, in the nature of reagents for diagnosing infectious diseases for medical purposes; diagnostic kits consisting of diagnostic reagents for detecting infectious diseases for medical purposes; preparations for preparing samples, for marking, separating, isolating, purifying, duplicating, sequencing and/or analyzing biomarkers, namely, diagnostic biomarkers for use in assessment of infectious diseases for medical use

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 22, 2026 RCSC
NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2025 NREP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 25, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 25, 2025 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 27, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 10, 2025 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 24, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 24, 2025 GNSL
SUSPENSION LETTER WRITTEN
Feb 24, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2025 TROA
REFUSAL PROCESSED BY IB
Aug 31, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 12, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 12, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 24, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 23, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 15, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 11, 2024 SDRC